Integrated and processed information on the following topics

• FDA Approved Drugs
• Medical indications
• Pharmacology toxicities
• Drugs interactions
• Ongoing clinical studies
• European and American guidelines
• Molecular Biomarkers for personalized medicine
• Real world data
• Best workflow to reduce medical effort
• Genomic Molecular Alterations
• Evaluation of oncogenic molecular panels
• Druggable vulnerabilities
• Targeted agents
• Therapeutic opportunities
• Identification of best treatment based on proprietary algorithms
• Potential target inhibition
• Current clinical development
• Competitive landscape
• Target population and indication
• Evaluation of attrition rate
• Pharma intelligent
• Intellectual property protection•
• Licensing and business deals
• Identification of best clinical development

.